Connect with us

Cannabis News

How Cannabis Outsmoked COVID-19 – The Data Tells Us Cannabis Users Had a Much Easier Time with COVID than Non-Users

Published

on


cannabis for covid-19

Cannabis helps people ride all types of waves, from work stress to creativity blocks. But its most impressive feat yet may be helping consumers weather the COVID storm far better than non-users.

Exciting new research presented at the American College of Chest Physicians conference found hospitalized COVID patients who used cannabis had significantly lower rates of intubation, respiratory issues, organ failure, cardiac arrest, and death compared to non-consumers.

This data reinforces earlier studies showing better COVID outcomes among cannabis patients. It adds to the scientific case that humanity’s oldest plant ally uniquely equips our biology for resilience against all types of challenges, even novel viruses.

The large-scale study analyzed over 300,000 medical records, with approximately 1% of patients identified as regular cannabis consumers. After carefully controlling for demographics and comorbidities, a striking pattern emerged – cannabis patients faced reduced COVID complications and death rates up to three times lower than non-users!

This protective effect very likely arises from the many anti-inflammatory, antiviral, and immune-modulating properties of cannabis compounds. Though the exact biological mechanisms require more research, the epidemiological evidence clearly indicates this plant can give humans a crucial advantage against the worst pandemic in generations.

Cannabis’s rich pharmacopeia likely bolsters cellular defenses, preventing viral entry and replication. Its antioxidant and neuroprotective effects could also mitigate severe cytokine immune reactions that drive respiratory distress.

Additionally, cannabis enhances cardiovascular function and balances metabolism – key benefits in countering COVID-induced blood and oxygen issues. The science is still early, but this seminal study proves cannabis engagement holds profound promise against infectious disease.

Beyond physiological factors, cannabis may also protect by promoting psychologically-healthy lifestyles. Studies show consumers average better diet quality, exercise more, and have lower stress and depression. This translates into stronger mental fitness to navigate COVID’s emotional toll.

Of course, reckless stoner stereotypes tempt prohibitionists to dismiss this harm-reducing herb. But science confirms cannabis prudently consumed as part of a balanced lifestyle offers holistic protective benefits we’re only beginning to understand. Open minds will soon recognize its profound applications.

Does cannabis cure COVID? No single remedy exists for such complex pathogens. However, humans have consumed this ally for thousands of years to bolster resilience and healing. COVID provides an opportunity to reinvestigate the excluded wisdom of traditional plant cures.

The ridiculous Catch-22 of prohibition is that barriers to research continue preventing full understanding of cannabis’s benefits! These exciting findings should inspire further urgent study of how cannabis compounds combat respiratory illness. Living evidence already shows this plant’s power if we open our eyes.

While risks exist for all substances, cannabis proves far more forgiving than pharmaceuticals like fentanyl and oxycontin that devastate societies. Yet only the capitalist-driven opioids enjoy FDA approval and trillions in subsidies – anything natural threatening those profits is suppressed.

But truth always overcomes entrenched interests in time. Cannabis prohibition is the irrationality of yesteryear – an embarrassing remnant of “reefer madness” propaganda dominating misinformed groupthink rather than individual choice. Medicine advances not through silencing mavericks, but welcoming iconoclasts.

The steadily growing mass of data reveals cannabis, carefully and mindfully applied, as a potentially revolutionary healing ally if given the opportunity. Its stigmatized reputation may still limit minds, but our bodies know the truth. The relief that graceful plant provides is beyond authorities’ power to deny.

Medical Cannabinoids Expanded!

Cannabis contains over 100 distinct therapeutic compounds that interact synergistically to provide wide-ranging medicinal effects. Beyond just THC and CBD, minor cannabinoids and terpenes each offer unique health benefits backed by a growing body of research. Let’s explore some of the most prominent:

THC The most famous cannabis molecule, THC provides relief for conditions like chronic pain, nausea, appetite loss, and insomnia. Studies show it effectively reduces migraine severity and shows promise in inflammatory diseases. THC also enhances mood and creative flow. Downsides include anxiety and impairment at high doses.

CBD – The second most abundant cannabinoid, CBD calms anxiety and pain perceptions. It protects neurological health, reduces inflammation and seizures, improves sleep quality, and elevates mood. CBD also appears to inhibit viral entry and ease opioid cravings. It’s non-intoxicating at most doses.

THCV – THCV shares similarities with THC but with faster onset. While research is limited, early studies suggest THCV curbs appetite and has neuroprotective properties. It may also benefit conditions like diabetes and Alzheimer’s disease. Expect focused cerebral effects that stimulate without paranoia.

CBG – CBG is considered the “mother cannabinoid” that gets converted into THC, CBD, and others. On its own, CBG is a powerful anti-inflammatory and painkiller. Research indicates therapeutic potential for cancers, Huntington’s disease, MRSA infections, and gastrointestinal disorders.

CBDV – One of the lesser known cannabinoids, CBDV has demonstrated effects similar to CBD as an anticonvulsant and appetite suppressant. However, it also appears to benefit conditions like epilepsy and nausea more potently than CBD in initial trials. More research is still needed.

CBN – CBN emerges from the degradation of THC. Its pronounced sedative qualities make CBN an excellent sleep aid. Studies also show it potentiates THC’s effects while reducing associated impairments. Those needing deep rest find value in CBN’s comforting arms.

THCA – Before decarboxylation into THC, the raw acidic form THCA contains low psychoactivity but high anti-inflammatory properties. Research links THCA to reduced systemic inflammation in conditions like lupus, neurodegeneration, and nausea. Dosing non-decarboxylated cannabis preserves THCA’s benefits.

CBDA – The raw form of CBD abundant in live cannabis, CBDA exhibits stronger anti-inflammatory and anti-nausea effects than CBD. Studies suggest CBDA holds promise for treating pain, seizures, digestive issues, and disorders involving excessive immune response. Like THCA, it gets destroyed by heating.

These are just a sampling of the diverse medical molecules found in cannabis. We’ve only scratched the surface of minor cannabinoids like CBC, CBE, CBT, and THCV. Myriad terpenes like pinene, limonene, and linalool also modulate effects.

Cannabis research remains bottlenecked by prohibition, but the compounds revealed so far exhibit enormous potential. The entourage effect describes how they work synergistically, balancing side effects while enhancing therapeutic impact.

Whole-plant cannabis medicine cannot be distilled down to any single “active” element. Rather, its healing essence results from specialized molecules cooperating in ways science is only beginning to grasp.

While isolating compounds enables precision, studying cannabis solely by reductionist methods has limitations. Holistic insights arise from honoring its innate complexity beyond the sum of parts.

As prohibition crumbles, harnessing cannabis’s full medical potential requires boldly probing past “reefer madness” indoctrination. We must let the entire orchestra play, not just THC and CBD soloists. Keeping an open mind allows us to hear nature’s subtle melodies.

Of course, more research is imperative to properly calibrate cannabis’s risks alongside benefits. But its established value for so many conditions gives hope that many ailments can be treated or prevented if we adequately understand the keys in this botanical treasure chest.

The Missed Opportunity of Legalization

Cannabis legalization offers exciting new directions for medicine. But as long as prohibition mindsets restrict research, we miss out on this plant’s boundless healing potential. Tragically, the same suppression applies to other banned psychedelics and entheogens.

Despite promising studies on psilocybin, LSD, ibogaine, and others, the war on drugs blocks inquiry into their therapeutic applications. This denialism breeds untold suffering for patients who could benefit from these safe psychoactive tools.

The parasitic status quo in our healthcare system is the true obstacle to progress. Giant pharmaceutical corporations define bone fide medicine solely as the synthetic drugs they can patent, manufacture, and control.

This profit-driven monopoly lead firms to suppress plant medicines that patients could grow themselves, eliminating dependence on pills. Why tolerate competition from cheap, unpatentable plants offering better outcomes? It threatens the bottom line!

Thus prohibition serves big pharma, not public health. It funnels sick people towards corporate symptom-management rather than the holistic healing plants provide. Keeping nature illegal ensures lifelong customers.

Tragically, the masses have been conditioned to accept ruthless pharma dominance over personal health. But no institution should wield such power over access to healing. True liberty means cognitive autonomy and sovereignty over one’s own mind, body, and consciousness.

And the mounting evidence for cannabis and psychedelics proves people can responsibly guide their own paths to wellness through sacred plants. Trusting innate wisdom and community support fosters growth, not blind obedience to the prescriptions of an uncaring system.

Access to nature’s remedies cannot remain controlled by profiteers who synthesized opioids now ravaging society. Their hypocrisy forbidding plant competition while peddling addiction reveals where true motives lie.

The time has come for radical reassessment of what constitutes legitimate medicine. Is it only what governments and corporations deem acceptable? Or should liberty extend into our minds and physiology, not just material rights?

Cannabis legalization must herald renegotiation of this twisted paternalism masquerading as health policy. Patients themselves should determine which tools foster healing and balance on their unique journeys.

And our own eyes confirm the plants targeted for eradication since Nixon’s racist drug war hold unmatched power to cure. Only the profit logic demands their suppression. But that predatory paradigm now dies.

The door of perception inches open as prohibition’s veil lifts. Inspiring pioneers lead the way. But true freedom for the generations after us requires dismantling the structures still blocking nature’s secrets.

Authorities want us docile, numb, and conforming to fill corporate medicine’s coffers. Yet within each of us, the sovereign spirit yearns to fly free. All that’s required is courage to open the cage – and see we’ve already had wings all along.

 

CANNABIS FOR COVID, WATCH THIS INTERVIEW, READ ON…

CANNABIS STOPS COVID CELL PATHWAYS

HOW CANNABIS HELPS BLOCK COVID IN THE HUMAN BODY?



Source link

Cannabis News

Latest Trump Weed Rumor – Trump Will Federally Deschedule and Decriminalize Cannabis, but Not Legalize It

Published

on

By


trump on marijuana reform

In a recent interview, former New Jersey Governor Chris Christie made headlines by asserting that President-elect Donald Trump will pursue significant reforms in federal policies regarding marijuana and cryptocurrency. As the nation grapples with evolving attitudes toward cannabis and the burgeoning digital currency market, Christie’s predictions have ignited discussions about the potential implications of such changes on both industries. This article delves into Christie’s insights, the current state of marijuana and cryptocurrency regulations, and the broader implications of these anticipated reforms.

 

The Current Landscape of Marijuana Legislation

 

Federal vs. State Laws

Marijuana remains classified as a Schedule I substance under the Controlled Substances Act (CSA), which places it in the same category as heroin and LSD. This classification has created a complex legal landscape where states have moved to legalize cannabis for medical and recreational use, while federal law continues to impose strict prohibitions. As of now, over 30 states have legalized marijuana in some form, leading to a burgeoning industry that generates billions in revenue.

 

Challenges Faced by the Cannabis Industry

 

Despite its legality in many states, the cannabis industry faces significant hurdles due to federal restrictions. These challenges include:

  • Banking Access: Many banks are hesitant to work with cannabis businesses due to fear of federal repercussions, forcing these businesses to operate largely in cash.

  • Taxation Issues: The IRS enforces Section 280E of the tax code, which prohibits businesses engaged in illegal activities from deducting normal business expenses, leading to disproportionately high tax burdens for cannabis companies.

  • Interstate Commerce: The lack of federal legalization prevents cannabis businesses from operating across state lines, limiting their growth potential.

 

Chris Christie’s Perspective on Marijuana Reform

 

Christie, a former presidential candidate known for his tough stance on drugs during his tenure as governor, has evolved his views on marijuana over the years. In his recent statements, he emphasized that Trump is likely to pursue descheduling cannabis, which would remove it from the Schedule I classification. This move would not only provide clarity for businesses operating in legal markets but also open avenues for banking and investment.

 

Christie highlighted that descheduling would allow for a more regulated market where safety standards could be established, thus protecting consumers. He believes that this approach aligns with a growing consensus among Americans who support legalization and recognize the potential benefits of cannabis use for both medical and recreational purposes.

 

The Future of Cryptocurrency Regulation = The Rise of Cryptocurrencies

 

Cryptocurrencies have surged in popularity over the past decade, with Bitcoin leading the charge as the first decentralized digital currency. The market has expanded to include thousands of alternative coins (altcoins), each with unique features and use cases. As cryptocurrencies gain traction among investors and consumers alike, regulatory scrutiny has intensified.

 

Current Regulatory Challenges

 

The cryptocurrency market faces several regulatory challenges that hinder its growth and adoption:

 

  • Lack of Clarity: Regulatory frameworks vary significantly across states and countries, creating confusion for investors and businesses.

  • Fraud and Scams: The rapid growth of cryptocurrencies has led to an increase in fraudulent schemes targeting unsuspecting investors.

  • Consumer Protection: Without clear regulations, consumers are often left vulnerable to risks associated with volatile markets.

 

Christie’s Vision for Crypto Regulation

 

Christie believes that under Trump’s leadership, there will be an effort to find a “sweet spot” for cryptocurrency regulation balancing innovation with consumer protection. He argues that overly stringent regulations could stifle growth in this emerging sector while too little oversight could expose consumers to significant risks.

 

In his view, a balanced regulatory framework would include:

 

1. Clear Definitions: Establishing clear definitions for different types of cryptocurrencies and tokens to differentiate between securities and utility tokens.

2. Consumer Protections: Implementing measures to protect investors from fraud while promoting transparency within the market.

3. Encouraging Innovation: Creating an environment conducive to innovation by allowing startups to thrive without excessive regulatory burdens.

 

Christie’s insights reflect a growing recognition among policymakers that cryptocurrencies are here to stay and that appropriate regulations are necessary to foster growth while safeguarding consumers.

 

Implications of Proposed Reforms

 

Economic Impact

 

The potential reforms proposed by Christie could have far-reaching economic implications:

 

  • Job Creation: Legalizing marijuana at the federal level could lead to significant job creation within the cannabis industry—from cultivation and production to retail sales.

  • Investment Opportunities: Descheduling cannabis would open up investment opportunities for institutional investors who have been hesitant due to federal restrictions.

  • Boosting Local Economies: Legal cannabis markets have proven beneficial for local economies through increased tax revenues and job creation.

 

Similarly, clear regulations around cryptocurrencies could stimulate investment in blockchain technology and related industries, fostering innovation and economic growth.

 

Social Justice Considerations

 

Both marijuana legalization and sensible cryptocurrency regulations have social justice implications:

 

  • Addressing Past Injustices: Legalizing marijuana could help rectify past injustices related to drug enforcement policies that disproportionately affected marginalized communities.

  • Financial Inclusion: Cryptocurrencies offer opportunities for financial inclusion for those underserved by traditional banking systems, particularly in low-income communities.

 

Political Landscape

 

The political landscape surrounding these issues is complex. While there is bipartisan support for marijuana reform among certain lawmakers, challenges remain in overcoming entrenched opposition. Similarly, cryptocurrency regulation has garnered attention from both sides of the aisle but requires collaboration to establish effective frameworks.

 

Conclusion

 

Chris Christie’s predictions about President-elect Donald Trump’s approach to federal marijuana descheduling and cryptocurrency regulation suggest a potential shift in U.S. policy that could significantly reshape both industries. As public opinion evolves on these issues, lawmakers have an opportunity to enact meaningful reforms that promote economic growth while ensuring consumer protection. The anticipated changes could foster a more robust cannabis industry that contributes positively to the economy and addresses social justice concerns, while clear regulatory frameworks for cryptocurrencies could encourage innovation and protect consumers in the digital economy. Stakeholders in both sectors are closely watching these developments, eager to see how potential reforms might impact their futures. While the realization of Christie’s predictions remains uncertain, it’s clear that the conversation around marijuana and cryptocurrency regulation is ongoing and far from settled.

 

TRUMP 2.0 ON CANNABIS REFORM, READ ON…

TRUMP ON MARIJUANA REFORM

TRUMP 2.0 ON FEDERAL CANNABIS REFORM – WHAT DO WE KNOW?

 



Source link

Continue Reading

Cannabis News

Webinar Replay: Post-Election Cannabis Wrap – Smoke ’em if You’ve Got ’em

Published

on

By


On Thursday, November 7th, Vince Sliwoski, Aaron Pelley and Fred Rocafort held a post election discussion “Post-Election Cannabis Wrap – Smoke ’em if You’ve Got ’em”. Watch the replay!

Key Takeaways from the “Smoke ’em if You’ve Got ’em – 2024 Post Election Cannabis Wrap” Webinar:

  1. Panelists:
    • Vince Sliwoski: Oregon Business lawyer specializing in cannabis and commercial real estate.
    • Aaron Pelley: Experienced in cannabis law since Washington’s legalization in 2012.
    • Fred Rocafort: Trademark attorney working closely with the cannabis team.
  2. Election Results Overview:
    • Most 2024 cannabis ballot measures did not pass.
    • Florida, South Dakota, and North Dakota saw failures.
    • Nebraska became the 39th state to legalize cannabis for medical use when it passed two cannabis initiatives, Initiatives 437 and 438.
  3. Federal and State-Level Developments:
    • Medical use is currently legal in 38 states, and 24 states allow recreational use.
    • Republican support for marijuana legalization is growing.
  4. Federal Policy Implications:
    • Schedule III Rescheduling: The process to move cannabis to Schedule III is ongoing, which could significantly impact the industry.
    • Importance of Federal Appointments: The future of cannabis policy depends heavily on who is appointed to key positions in the administration.
  5. International and Domestic Trade:
    • Schedule III status could ease import/export restrictions on cannabis.
    • Unified control of House, Senate, and presidency might expedite legislative progress.
  6. Economic and Industry Impact:
    • Cannabis stocks experienced volatility post-election, reflecting investor uncertainty.
    • Federal legalization and banking reforms are crucial for industry stability and growth.
  7. Future Outlook:
    • The potential for federal rescheduling remains strong, with hearings scheduled for early 2025.
    • State-level initiatives and regulatory developments will continue to shape the industry.

Watch the replay!



Source link

Continue Reading

Cannabis News

I Had Just One Puff

Published

on

By


one puff of a joint a drug test

“How Long Does One Puff of Weed Stay in Your System?”… This topic can be difficult to answer since it is dependent on elements such as the size of the hit and what constitutes a “one hit.” If you take a large bong pull then cough, it might linger in your system for 5-7 days. A moderate dose from a joint can last 3-5 days, whereas a few hits from a vaporizer may last 1-3 days.

 

The length of time that marijuana stays in the body varies based on a number of factors, including metabolism, THC levels, frequency of use, and hydration.

 

Delta-9-tetrahydrocannabinol, or THC, is the primary psychoactive component of cannabis. THC and its metabolites, which remain in your body long after the effects have subsided, are detected by drug tests.

 

Since these metabolites are fat-soluble, they cling to bodily fat molecules. They could thus take a while to fully pass through your system, particularly if your body fat percentage is higher.

 

THC is absorbed by tissues and organs (including the brain, heart, and fat) and converted by the liver into chemicals such as 11-hydroxy-THC and carboxy-THC. Cannabis is eliminated in feces at a rate of around 65%, while urine accounts for 20%. The leftover amount might be kept within the body.

 

THC deposited in bodily tissues ultimately re-enters the circulation and is processed by the liver. For frequent users, THC accumulates in fatty tissues quicker than it can be removed, thus it may be detectable in drug tests for days or weeks following consumption.

 

The detection time varies according to the amount and frequency of cannabis usage. Higher dosages and regular usage result in longer detection times.

 

The type of drug test also affects detection windows. Blood and saliva tests typically detect cannabis metabolites for shorter periods, while urine and hair samples can reveal use for weeks or even months. In some cases, hair tests have detected cannabis use over 90 days after consumption.

 

Detection Windows for Various Cannabis Drug Tests

 

Urine Tests

Among all drug tests, urine testing is the most commonly used method for screening for drug use in an individual.

 

Detection times vary, but a 2017 review suggests the following windows for cannabis in urine after last use:

 

– Single-use (e.g., one joint): up to 3 days

– Moderate use (around 4 times a week): 5–7 days

– Chronic use (daily): 10–15 days

– Chronic heavy use (multiple times daily): over 30 days

 

Blood Tests

Blood tests generally detect recent cannabis use, typically within 2–12 hours after consumption. However, in cases of heavy use, cannabis has been detected up to 30 days later. Chronic heavy use can extend the detection period in the bloodstream.

 

Saliva Tests

THC can enter saliva through secondhand cannabis smoke, but THC metabolites are only present if you’ve personally smoked or ingested cannabis.

 

Saliva testing has a short detection window and can sometimes identify cannabis use on the same day. A 2020 review found that THC was detectable in the saliva of frequent users for up to 72 hours after use, and it may remain in saliva longer than in blood following recent use.

 

In areas where cannabis is illegal, saliva testing is often used for roadside screenings.

 

Hair Tests

Hair follicle tests can detect cannabis use for up to 90 days. After use, cannabinoids reach the hair follicles through small blood vessels and from sebum and sweat surrounding the hair.

 

Hair grows at approximately 0.5 inches per month, so a 1.5-inch segment of hair close to the scalp can reveal cannabis use over the past three months.

 

Factors Affecting THC and Metabolite Retention

 

The length of time THC and its metabolites stay in your system depends on various factors. Some, like body mass index (BMI) and metabolic rate, relate to individual body processing, not the drug itself.

 

Other factors are specific to cannabis use, including:

 

– Dosage: How much you consume

– Frequency: How often you use cannabis

– Method of consumption: Smoking, dabbing, edibles, or sublingual

– THC potency: Higher potency can extend detection time

 

Higher doses and more frequent use generally extend THC retention. Cannabis consumed orally may remain in the system slightly longer than smoked cannabis, and stronger cannabis strains, higher in THC, may also stay detectable for a longer period.

 

How Quickly Do the Effects of Cannabis Set In?

 

When smoking cannabis, effects appear almost immediately, while ingested cannabis may take 1–3 hours to peak.

 

The psychoactive component THC produces a “high” with common effects such as:

 

– Altered senses, including perception of time

– Mood changes

– Difficulty with thinking and problem-solving

– Impaired memory

 

Other short-term effects can include:

– Anxiety and confusion

– Decreased coordination

– Dry mouth and eyes

– Nausea or lightheadedness

– Trouble focusing

– Increased appetite

– Rapid heart rate

– Restlessness and sleepiness

 

In rare cases, high doses may lead to hallucinations, delusions, or acute psychosis.

 

Regular cannabis use may have additional mental and physical effects. While research is ongoing, cannabis use may increase the risk of:

 

– Cognitive issues like memory loss

– Cardiovascular problems including heart disease and stroke

– Respiratory illnesses such as bronchitis or lung infections

– Mood disorders like depression and anxiety

 

Cannabis use during pregnancy can negatively impact fetal growth and development.

 

Duration of Effects

Short-term effects generally taper off within 1–3 hours, but for chronic users, some long-term effects may last days, weeks, or even months. Certain effects may even be permanent.

 

Bottom Line

The amount of time that cannabis remains in your system following a single use varies greatly depending on individual characteristics such as body fat, metabolism, frequency of use, and mode of intake. Frequent users may maintain traces of THC for weeks, whereas infrequent users may test positive for as little as a few days. Hair tests can disclose usage for up to 90 days, while blood and saliva tests identify more recent use. Urine tests are the most popular and have varying detection durations. The duration that THC and its metabolites are detectable will ultimately depend on a number of factors, including dose, strength, and individual body chemistry.

 

PEE IN A CUP COMING UP, READ ON..

how long does weed stay in your urine

HOW LONG DOES WEED STAY IN YOUR URINE FOR A DRUG TEST?



Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media